Join to view full profile
40 Duke Medicine CirDurham, NC 27710
Phone+1 919-684-8111
Fax+1 919-620-4921
Dr. Sarantopoulos is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2002 - 2005
Boston University Medical CenterResidency, Internal Medicine, 1998 - 2002
Boston University School of MedicineClass of 1998
Boston University School of MedicinePh.D., 1998- Mount Holyoke CollegeB.A., Biochemistry, 1988
Certifications & Licensure
NC State Medical License 2009 - 2027
MA State Medical License 2001 - 2009
American Board of Internal Medicine Hematology
ABIMHematology
Awards, Honors, & Recognition
- American Society for Clinical Investigation ASCI, 2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
Clinical Trials
Publications & Presentations
PubMed
- Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairment.Matthew A Bergens, Matthew Braun, Ernaya J Johnson, Yan Li, Jamie S Myers
Bone Marrow Transplantation. 2026-06-01 - Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.Allison O Taylor, Joshua S Mercer, Claire I Bradbury, Samantha M Thomas, Edwin Alyea 3rd
Bone Marrow Transplantation. 2026-06-01 - Multisystemprogression on fosmanogepix despiteactivity: a call for expanding clinical research on novel antifungals.Ryan A Cooper, Sana Arif, Arthur W Baker, Nathan P Wiederhold, Stefanie Sarantopoulos
ASM Case Reports. 2026-03-01
Journal Articles
- Notch Signaling Mediated by Delta-like1/4 Ligands Controls the Pathogenesis of Chronic Graft-Versus-Host Disease in MiceIvan Maillard, Eric T Perkey, Stefanie Sarantopoulos, Blood
- Review: Hematopoietic Stem Cell Transplantation for Scleroderma: Effective Immunomodulatory Therapy for Patients with Pulmonary InvolvementKeith M Sullivan, Ankoor Shah, Daniel E Furst, Stefanie Sarantopoulos, Arthritis & Rheumatology
- A randomized phase II crossover study of imatinib or rituximab for cutaneous sclerosis after hematopoietic cell transplantationAria S, Pidala J, Pusic I, Chai X, Jaglowski S, Khera N, Plamer J, Chen GL, Jagasia M, Mayer SA, Wood WA, Green M, Hyun TS, Inamoto Y, Storer BE, Miklos DB, Shulman HM..., Clin Cancer Res, 1/1/2015
Abstracts/Posters
- Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host DiseaseStefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...Stefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell TransplantationStefanie Sarantopoulos, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lectures
- B cells in Chronic GVHD1/18/2015
- Burgeoning Roles of B Cells in Transplant1/1/2013
- B Cells and TransplantationTampa, FL - 1/1/2009
Other
- Generation of recombinant polyclonal antibody libraries against tumor cells (thesis)Sarantopoulos S, Boston University School of Medicine
Boston, MA - 1/1/1996 - Separation of monomers and dimmers of glyceraldehydes-3-phosphate dehydrogenase (thesis)Sarantopoulos S, Mt. Holyoke College
South Hadley, MA - 1/1/1988
Press Mentions
Axatilimab Shows Robust Activity in Chronic Graft-Versus-Host-Disease TrialDecember 20th, 2023
Grant Support
- Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHDDUKE UNIVERSITY2015–2031
- Harnessing B Cells after Stem Cell Transplant to Produce Novel CAR-TsDUKE UNIVERSITY2025–2027
- Pathological B Cells: Novel Strategies to Prevent and Treat Chronic GVHDNIH (NHLBI)2015–2020
- The Notch2-BCR Axis: Targeting Drivers of B Cell Fate in Chronic GVHDThe Leukemia & Lymphoma Society2015–2018
Committees
- Elected Board Member, Director of Laboratory Sciences for American Society of Bone Marrow Transplantation 2018 - Present
- Invited member, NIH Consensus Criteria on Chronic Graft versus Host Disease, subcommittee on Biology and Biomarkers 2013 - Present
- Invited member, Autoimmune Diseases and Cell Therapy Working for the CENTER FOR INTERNATIONAL BLOOD & MARROW TRANSPLANT RESEARCH (CIBMTR) Committee 2013 - Present
Professional Memberships
- Member
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: